(Q36601503)

English

A single in vivo administration of bombesin antagonist RC-3095 reduces the levels and mRNA expression of epidermal growth factor receptors in MXT mouse mammary cancers

scientific article published on September 1997

Statements

A single in vivo administration of bombesin antagonist RC-3095 reduces the levels and mRNA expression of epidermal growth factor receptors in MXT mouse mammary cancers (English)
10913-10918

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit